Dr. Brad Nelson

Dr. Nelson received training at the University of California at Berkeley (Ph.D.) and Fred Hutchinson Cancer Research Center (postdoc), and in 2003 became founding Director of the Deeley Research Centre.  His laboratory is pursuing the development of innovative immunotherapies for cancer.  Areas of focus include: understanding how tumour-reactive T cells and B cells promote survival of cancer patients; using genomic and bioinformatic methods to decipher the barriers to effective immunotherapy; and using the power of genetic engineering to create more precise and potent immune cells for use in immunotherapy.